Oct 2026· Advancement of science· 0 citations· 178 references
Medicine
TL;DR
This work critically synthesizes the cellular mechanisms enabling mitoTT, emphasizing the checkpoints that determine whether transferred mitochondria are integrated, remodeled, immunologically sensed, or eliminated.
Abstract
ABSTRACT Mitochondrial transfer and transplantation (mitoTT) has emerged as an experimental and potentially transformative therapeutic strategy, drawing attention for its ability to modulate cellular bioenergetics, stress responses, and tissue repair. Endogenous mitochondrial transfer can occur through tunneling nanotubes, extracellular vesicles, cell fusion, gap junction‐associated communication, and phagocytosis‐like internalization. These routes differ substantially in distance, directionality, cargo integrity, regulatory control, and physiological relevance. Preclinical studies indicate that exogenous mitochondria may transiently improve bioenergetic function, attenuate oxidative stress, and support recovery in models of cardiac, skeletal muscle, and nervous system injury, whereas clinical evidence remains limited and heterogeneous. Broad clinical implementation remains constrained by unresolved biological and translational barriers. These include inefficient or poorly controlled uptake of extracellular mitochondria, uncertain long‐term persistence, incomplete functional integration, donor‐recipient incompatibility, mitochondrial‐nuclear mismatch, heteroplasmy‐related risks, immunogenicity, and the lack of standardized potency and delivery assays. Here, we critically synthesize the cellular mechanisms enabling mitoTT, emphasizing the checkpoints that determine whether transferred mitochondria are integrated, remodeled, immunologically sensed, or eliminated. We further discuss cristae biology and the mitochondrial contact site and cristae organizing system, mitochondrial nucleoid maintenance, mitochondrial DNA replication, organelle contact sites, and emerging bioengineering strategies required to move mitoTT from experimental rescue toward reproducible therapeutic application.
Cells exhibit innate reparative communication, enabling the exchange of bioactive molecules and, in some cases, entire organelles. Harnessing this endogenous process of intercellular organelle transfer represents an emerging therapeutic paradigm for restoring cellular function in diseases driven by organelle dysfunctio...
John Soukar, K. Jones, Natalie M. Garza et al.· Science Advances· 0 citations
Abstract Background Mitochondrial transplantation is built on a simple idea: failing cells might be rescued by healthy mitochondria. The approach has entered early clinical testing, and encapsulation and cell‐type targeting have improved uptake in selected systems. Better delivery, however, does not explain the therapy...
Zhi-Yuan Zhang, Bo-Quan Qin, Shi-Zhou Wu et al.· Clinical and Translational M...· 0 citations
Mitochondrial dysfunction underlies multiple forms of renal injury, prompting strategies to restore organellar function rather than target discrete signaling pathways. Mitochondrial transplantation (MTx) has produced short-term functional, histological, or cellular benefits in preclinical models of renal ischemia-rep...
Yu Cheng, Hong Liu, Kai-Feng Zheng et al.· Frontiers in Physiology· 0 citations
Abstract Ischemic stroke remains a leading cause of death and disability, and mitochondrial dysfunction links bioenergetic failure, oxidative stress, neuroinflammation, blood–brain barrier (BBB) injury, and cell death. Despite extensive preclinical neuroprotection research, translation has often failed because candidat...
Ye-Wu Ding, Xiu-Fei Teng, Ting-Yi Guo et al.· International Journal of Nan...· 0 citations
This review delineates how mitochondrial transfer exerts dual effects on antitumor immunity: tumor cells hijack functional mitochondria from T cells, macrophages, and stromal cells to fuel their proliferation and therapy resistance, while simultaneously delivering mutant mitochondria to immune cells to drive exhaustion...